The company will use the money to try to establish its cuffless device as a go-to option for 24-hour blood pressure ...
Biobeat Technologies has raised $50 million in a series B round to help boost the commercialization of its blood pressure ...
A recently published study in the New England Journal of Medicine shows that 24-hour ambulatory blood pressure monitoring is a better predictor of cardiovascular and all-cause mortality than just ...
A pilot program between RWJBarnabas Health and the Liberty Science Center‘s SciTech Scity Healthcare Innovation Engine is showing the vast potential of digital health solutions. Biobeat, a medtech ...
Biobeat closed a $50M Series B, led by Ally Bridge, OrbiMed, and Elevage, to expand U.S. commercialization of its 24 hour FDA ...
Hosted on MSN
Scientists make major blood pressure breakthrough with new drug that offers 24 hour protection
A newly developed drug has been found to offer 24 hour protection from high blood pressure, including early mornings when the risk of heart attacks and stroke is highest. Blood pressure is strongly ...
NEW YORK (Reuters Health) - For tracking heart risk, taking blood pressure readings regularly at home beats out measurements in the doctor's office, or even expensive 24-hour blood pressure monitoring ...
Huawei is reportedly preparing to introduce its next smartwatch in India. According to recent leaks, the upcoming wearable may include advanced health tracking features not commonly seen on wrist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback